Blog Category

Tag: RetroSense Therapeutics

Navigate all the resources featured in the Landscape Guide by geographic location, industry sector, and organization type. Landscape Guide
Everything you need to know to make a meaningful first connection can be found in our 2021-22 Landscape Guide! Download the Guide

2023 MVCA Research Report

Our state's entrepreneurial economy hinges on our ability to provide capital to our high-growth, high-potential companies. Download the Report
October 07 RetroSense Therapeutics, Exit of the Year!

The team at RetroSense Therapeutics, seasoned veterans with experience taking medical technology from the discovery stage to the clinic, knew 2016 could be a breakout year for the company.  RetroSense’s therapy, based on research conducted at Wayne State University in Detroit, was almost ready for its biggest test yet: a Phase I/II clinical trial.  In […]


Read More
September 07 RetroSense Therapeutics’ investors see exit, bright future ahead

An investment made by several groups of early-stage Michigan investors could pay off in a big way following the recent news that Allergan acquired Ann Arbor-based RetroSense Therapeutics LLC, a Michigan angel-backed gene therapy company, for $60 million plus additional funding if the company reaches future milestones. Terry Cross, MVCA member, and director of RetroSense […]


Read More
April 21 Angel-backed RetroSense Therapeutics Recognized as National Innovator

Angel investors might invest in one of every 100 opportunities that come before them—long odds for a startup, for sure. Ann Arbor-based RetroSense Therapeutics, a privately-held biopharmaceutical company, had already beat those odds, having raised $7 million in a 2014 angel-led Series A financing round that included Midland’s Blue Water Angels Investment Network. But the […]


Read More